Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
Main Authors: | Nikoletta Rovina, Karolina Akinosoglou, Jesper Eugen-Olsen, Salim Hayek, Jochen Reiser, Evangelos J. Giamarellos-Bourboulis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-020-02897-4 |
Similar Items
-
Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
by: Charlotte Höybye, et al.
Published: (2019-05-01) -
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
by: Christina-Alexandra Schulz, et al.
Published: (2017-03-01) -
Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
by: Dimitrios Velissaris, et al.
Published: (2020-05-01) -
Prospective use of soluble urokinase plasminogen activator receptor to screen TB co-infected with HIV patient among TB patient
by: Tri Yudani Mardining Raras, et al.
Published: (2017-10-01) -
Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
by: Pratyush Kumar, et al.
Published: (2019-01-01)